title: In reply.
authors.affiliation: Institut für Pharmakologie und Toxikologie, Technische Universität Dresden, Dresden, Germany (M.W.). michael_wagner@tu-dresden.de; or Institut für Zelluläre und Molekulare Physiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany (T.V.). tilmann.volk@fau.de.
authors.forename: Michael
authors.initials: M
authors.lastname: Wagner
authors.forename: York A
authors.initials: YA
authors.lastname: Zausig
authors.forename: Stefan
authors.initials: S
authors.lastname: Ruf
authors.forename: Elena
authors.initials: E
authors.lastname: Rudakova
authors.forename: Michael
authors.initials: M
authors.lastname: Gruber
authors.forename: Bernhard M
authors.initials: BM
authors.lastname: Graf
authors.forename: Tilmann
authors.initials: T
authors.lastname: Volk
mesh_terms: D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D002045:Bupivacaine / Q000494:pharmacology*; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology*; D005260:Female; D006352:Heart Ventricles / Q000187:drug effects*; D032383:Myocytes, Cardiac / Q000187:drug effects*; D015222:Sodium Channels / Q000187:drug effects*
chemical_list: D000779:Anesthetics, Local; D005217:Fat Emulsions, Intravenous; D015222:Sodium Channels; D002045:Bupivacaine